GFM Network News

The Bayer AG logo at the headquarters in France. Bayer AG has struck down its own plans to sell Nemastrike – a seed treatment designed to protect against nematodes – after reviewing experiences from farmers and applicators.  Photo: Reuters/Benoit Tessier/File

Bayer cancels plans to sell U.S. crop product in 2020 over safety concerns

Chicago | Reuters – Bayer AG has scrapped plans for wide sales next year of a chemical that is intended to protect U.S. crops from yield-robbing worms, citing ongoing safety concerns. The decision is the latest setback for Germany-based Bayer following its acquisition of Monsanto for $63 billion in 2018. Bayer is separately battling thousands of lawsuits claiming Monsanto’s glyphosate-based […] Read more